Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A4 | Q9H015 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 3/20 | 0.45 |
| ▸ | ALPL | P05186 | 1/20 | 0.45 |
| ▸ | ALPG | P10696 | 1/20 | 0.45 |
| ▸ | KDM6B | O15054 | 1/20 | 0.40 |
| ▸ | KDM4A | O75164 | 1/20 | 0.40 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.40 |
| ▸ | HIF1AN | Q9NWT6 | 1/20 | 0.40 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PIM1 | P11309 | 1/20 | 0.32 |
| ▸ | TTK | P33981 | 1/20 | 0.32 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29705505 | 0.89 | SLC22A4 (0.51) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL2954946 | 0.81 | SLC22A4 (0.52) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL2218757 | 0.81 | SLC22A4 (0.52) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL29418359 | 0.81 | SLC22A4 (0.52) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL188140 | 0.81 | SLC22A4 (0.52) | SLC22A4POLBALPLALPGGAA | |
| Water SCHEMBL7254213 | 0.80 | SLC22A4 (0.51) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL13201935 | 0.72 | SLC22A4 (0.35) | SLC22A4POLBALPLALPGKDM6B | |
| SCHEMBL26315497 | 0.72 | SLC22A4 (0.55) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL1331027 | 0.72 | SLC22A4 (0.55) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL29514561 | 0.71 | SLC22A4 (0.43) | SLC22A4POLBALPLALPGGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11504355-B2 | Ergothioneine compositions and methods for maintaining and/or increasing vitamin C levels in cells and organisms | MIRONOVA INNOVATIONS, LLC (US) | 2022-11-22 | — | — | US | claimed |
| US-20250134866-A1 | COMMENSAL SIGNALLING COMPOUNDS FOR TREATING OR PREVENTING MICROBIOME DYSFUNCTION IN THE SKIN OR MOUTH | Trampota Jan (US) | 2025-05-01 | — | — | US | disclosed |
| CN-114269722-B | Ergothioneine, S-methyl-ergothioneine and uses thereof | 贝尔维奇生物医学研究所(伊迪贝尔) | 2024-11-22 | — | — | CN | disclosed |
| CN-116897208-A | Process for the preparation of ergothioneine | 长濑产业株式会社 | 2023-10-17 | — | — | CN | disclosed |
| WO-2023150241-A1 | COMMENSAL SIGNALLING COMPOUNDS FOR TREATING OR PREVENTING MICROBIOME DYSFUNCTION IN THE SKIN OR MOUTH | Trampota Jan (US) | 2023-08-10 | — | — | WO | disclosed |
| US-11504355-B2 | Ergothioneine compositions and methods for maintaining and/or increasing vitamin C levels in cells and organisms | MIRONOVA INNOVATIONS, LLC (US) | 2022-11-22 | — | — | US | disclosed |
| US-20220265611-A1 | ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF | Consorcio Centro de Investigación Biomédica en Red, M.P. (ES) | 2022-08-25 | — | — | US | disclosed |
| US-20220265611-A1 | ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF | Consorcio Centro de Investigación Biomédica en Red, M.P. (ES) | 2022-08-25 | — | — | US | disclosed |
| EP-4004541-A1 | ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF | Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) (ES) | 2022-06-01 | — | — | EP | disclosed |
| EP-4004541-A1 | ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF | Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) (ES) | 2022-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220265611-A1 | ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF | BHMT2, GNMT, BHMT | SLC22A4 157/4885POLB 3203/4885ALPL 1439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.